ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
5.00
+0.21 (4.38%)
At close: Apr 1, 2025, 4:00 PM
5.10
+0.10 (2.00%)
After-hours: Apr 1, 2025, 4:35 PM EDT
ImmuCell Employees
As of December 31, 2023, ImmuCell had 79 total employees, including 74 full-time and 5 part-time employees. The number of employees increased by 5 or 6.76% compared to the previous year.
Employees
79
Change (1Y)
5
Growth (1Y)
6.76%
Revenue / Employee
$335,354
Profits / Employee
-$27,304
Market Cap
44.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ICCC News
- 4 weeks ago - ImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 - GlobeNewsWire
- 5 weeks ago - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 - GlobeNewsWire
- 2 months ago - ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses - GlobeNewsWire
- 2 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024 - GlobeNewsWire
- 4 months ago - ImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 5 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire